Farmapram ® ( Alprazolam )

Farmapram® is a brand name for alprazolam, a pharmaceutical compound classified as a benzodiazepine. Alprazolam is a central nervous system (CNS) depressant that works by enhancing the activity of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter responsible for reducing excessive neuronal activity in the brain.
Pharmacological Classification
Drug Class: Benzodiazepine
Active Ingredient: Alprazolam
Mechanism of Action: GABA-A receptor modulation
Therapeutic Category: Anxiolytic and sedative agent
Medical and Research Context
In clinical and research settings, alprazolam has been studied for its role in the management of anxiety disorders and panic disorders. Farmapram is manufactured and distributed in select regions under prescription control. Regulatory approval, availability, and medical guidelines vary internationally.
Safety, Risks, and Regulatory Status
Alprazolam is associated with well-documented risks, including:
Physical and psychological dependence
Tolerance with prolonged exposure
Withdrawal symptoms following abrupt discontinuation
Cognitive impairment and sedation
Due to these risks, alprazolam is designated as a controlled substance in many countries, and its use is typically restricted to short-term medical supervision. Unregulated or non-medical exposure can lead to serious health consequences.
Legal and Ethical Considerations
The legal classification of Farmapram and alprazolam differs by country and jurisdiction. Researchers and readers should consult local pharmaceutical regulations and official health authorities for accurate legal guidance.
Disclaimer
This content is provided strictly for educational and research purposes. It does not constitute medical advice, promote use, or encourage self-medication.